Our extensive research program is undertaken in line with standards of research used in the pharmaceutical industry, chiefly: Randomization: In our clinical trials including placebo groups, the participants are randomly allocated to the control group (placebo) or to the experimental group. This helps reduce the likelihood that any benefits or risks, that the researchers identify during the trials, will occur due to factors outside the experimental treatment. Control (Placebo): A placebo is an inactive substance that looks like the molecule being tested. Comparing results from the control group and the experimental group suggests whether changes in the experimental group resulted from the treatment or occurred by chance. Double-Blind: To avoid any biases in the results of our trials, neither the participants nor the researchers know which treatment (molecule being tested vs. placebo) is received until the clinical trial is over. Multiple-Dose: To fully characterize the pharmacokinetics of a molecule and its metabolites and thus explore its dose proportionality on intended effect.